SyneuRx International (Taiwan) Corp

Mission The mission of SyneuRx is to use a humanistic approach to bring breakthrough therapeutics to diseases and conditions where there are significant unmet needs. Antiviral Platform - Antiviral for COVID-19 Currently, SyneuRx is conducting two clinical programs of COVID-19 treatments Pentarlandir as an oral capsule and Airnecflu as an inhaled treatment. The companys COVID-19 efforts began in February 2020 as COVID-19 emerged to be a global pandemic, SyneuRx decided to apply its extensive R&D experience with CNS therapeutics toward R&D for COVID-19 antivirals in an effort to help develop a safe, effective, and accessible treatment that would prevent the progression and transmission of the disease. SyneuRx scientists arrived at the theory that regulatory enzymes such as protease would be a critically-important drug target for these types of illnesses, which coincidentally is also a target for several virally-caused diseases such as HIV and hepatitis. Researchers decided to tes...